The Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients with Various Degrees of Renal Function
- 1 April 1992
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 32 (4) , 344-350
- https://doi.org/10.1002/j.1552-4604.1992.tb03846.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.British Journal of Clinical Pharmacology, 1990
- Angiotensin-Converting Enzyme Inhibitors in Chronic Renal FailureDrugs, 1990
- Quinapril: A Double-Blind, Placebo-Controlled Trial in Essential HypertensionAngiology, 1989
- Preliminary Hemodynamic Report of the Efficacy and Safety of Quinapril in Acute and Chronic Treatment of Patients with Congestive Heart FailureAngiology, 1989
- Clinical Pharmacology of Quinapril in Healthy Volunteers and in Patients with Hypertension and Congestive Heart FailureAngiology, 1989
- Lisinopril pharmacokinetics in chronic renal failure.British Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal functionEuropean Journal of Clinical Pharmacology, 1988
- Pharmacokinetics of enalapril in normal subjects and patients with renal impairment.British Journal of Clinical Pharmacology, 1986
- Pilot Study of the Effects of the Angiotensin‐Converting Enzyme Inhibitor CI‐906 on Patients with Essential HypertensionThe Journal of Clinical Pharmacology, 1984
- Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.Hypertension, 1981